Stocksigma LogoStocksigma Logo

Rekvina Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 356 (+1712.5% YoY | +432.0% QoQ) ■ EBITDA: 26.8 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 7.5 (Loss to Profit YoY | Loss to

Rekvina Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Rekvina Laboratories Ltd · Financial Result · 13 Nov 2026, 11:40 pm

Rekvina Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 356 (+1712.5% YoY | +432.0% QoQ) ■ EBITDA: 26.8 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 7.5 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: 9.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.09 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Rekvina Laboratories Ltd

All Rekvina Laboratories Ltd announcements